ADMA Biologics, Inc. (ADMA) vs Alvotech (ALVO)

A side-by-side comparison of ADMA Biologics, Inc. and Alvotech across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADMA vs ALVO

growth of $100 · dividends reinvested · last 4y
ADMA +398.0% (+49.4%/yr)ALVO -45.4% (-14.0%/yr)ADMA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002023202420252026$498$55
ADMA ALVO

ADMA vs ALVO: by the numbers

  • •ADMA is the larger company ($2.34B vs $2.07B market cap).
  • •ADMA is profitable (32.98% net margin) while ALVO runs a net loss (-36.51%).
  • •ALVO grew revenue faster over the past five years (69.03% vs 54.55% CAGR).

Metrics side by side

Valuation

MetricADMAALVO
P/E ratio14.44N/A
Forward P/E12.69N/A
P/S ratio4.574.20
P/B ratio5.74N/A
EV / EBITDA10.6741.84
FCF yield4.97%N/A

Profitability

MetricADMAALVO
Gross margin64.71%60.45%
Operating margin42.26%9.62%
Net margin32.98%-36.51%
ROE41.39%N/A
ROIC27.60%3.61%

Growth (annualized)

MetricADMAALVO
Revenue CAGR (5Y)54.55%69.03%
Total return CAGR (5Y)54.74%N/A

Frequently asked

Which has grown faster, ADMA or ALVO?
Over the past five years, ALVO grew revenue faster — ADMA at a 54.55% CAGR versus ALVO at 69.03%.
Is ADMA or ALVO more profitable?
ADMA runs the higher net margin — ADMA at 32.98% versus ALVO at -36.51%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.